Characterization of Insulin Secretion in Valproate‐treated Patients with Epilepsy
- 13 September 2006
- Vol. 47 (9) , 1460-1464
Abstract
Summary: Purpose: Valproate (VPA) treatment has been reported to be associated with obesity and high fasting serum insulin concentrations in parallel with an unfavorable serum lipid profile and hyperandrogenism and polycystic ovaries in women. The pathogenetic mechanism underlying these changes has remained unknown, although several mechanisms have been implicated. Methods: Fifty‐one patients receiving monotherapy (31 male and 20 female patients) were included in this study, with 45 (23 male and 22 female) healthy control subjects. These participants were interviewed, clinically examined, and blood samples for fasting plasma glucose, serum insulin, proinsulin, and C‐peptide concentrations were taken after an overnight fast. Results: The valproate‐treated patients had fasting hyperinsulinemia (11.30 ± 6.23 pM vs. 6.28 ± 4.66 pM in the control subjects; p < 0.001), although the fasting serum proinsulin and C‐peptide concentrations were not significantly higher in the patients than in the control subjects. In addition, proinsulin/insulin (0.30 ± 0.14) and C‐peptide/insulin ratios (35.48 ± 24.09) were lower (p < 0.001) in the VPA‐treated patients when compared with the control subjects (0.53 ± 0.36 and 94.27 ± 61.85, respectively), and they also had lower fasting plasma glucose concentrations (4.72 ± 0.35 mM) than the control subjects (5.12 ± 0.58 mM; p < 0.01). Conclusions: This study suggests that valproate does not induce insulin secretion but might interfere with the insulin metabolism in the liver, resulting in higher insulin concentrations in the peripheral circulation. These changes are seen irrespective of concomitant weight gain, suggesting that increased insulin concentrations induce weight gain and not vice versa.Keywords
This publication has 30 references indexed in Scilit:
- Valproate therapy and nonalcoholic fatty liver diseaseAnnals of Neurology, 2004
- Anticardiolipin and antinuclear antibodies in epilepsy—a population-based cross-sectional studyEpilepsy Research, 2004
- Obesity and insulin resistanceJournal of Clinical Investigation, 2000
- Hyperinsulinemia and the Risk of Stroke in Healthy Middle-Aged MenStroke, 1998
- Valproic AcidDrugs, 1994
- Hyperinsulinaemia, obesity, and syndrome XJournal of Internal Medicine, 1994
- Valproate and palmitate binding to serum albumin in valproate-treated patients. relation to obesityEpilepsy Research, 1993
- Clustering of cardiovascular risk factors in confirmed prehypertensive individuals.Hypertension, 1992
- Proposal for Revised Clinical and Electroencephalographic Classification of Epileptic SeizuresEpilepsia, 1981
- HYPERINSULINISM OF HEPATIC CIRRHOSIS: DIMINISHED DEGRADATION OR HYPERSECRETION?The Lancet, 1977